Vanguard Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,745,266
Closed -$21.8M 4117
2020
Q1
$21.8M Buy
5,745,266
+41,315
+0.7% +$157K ﹤0.01% 2243
2019
Q4
$29M Buy
5,703,951
+50,590
+0.9% +$258K ﹤0.01% 2354
2019
Q3
$28.6M Buy
5,653,361
+189,657
+3% +$959K ﹤0.01% 2307
2019
Q2
$33.7M Buy
5,463,704
+364,803
+7% +$2.25M ﹤0.01% 2293
2019
Q1
$23.7M Buy
5,098,901
+1,541,314
+43% +$7.15M ﹤0.01% 2423
2018
Q4
$14.9M Sell
3,557,587
-1,488,844
-30% -$6.25M ﹤0.01% 2581
2018
Q3
$31.6M Buy
5,046,431
+727,575
+17% +$4.56M ﹤0.01% 2362
2018
Q2
$34.7M Buy
4,318,856
+278,661
+7% +$2.24M ﹤0.01% 2316
2018
Q1
$30.1M Sell
4,040,195
-29,405
-0.7% -$219K ﹤0.01% 2336
2017
Q4
$24.2M Sell
4,069,600
-301,421
-7% -$1.79M ﹤0.01% 2418
2017
Q3
$32.2M Buy
4,371,021
+70,543
+2% +$519K ﹤0.01% 2272
2017
Q2
$29.2M Buy
4,300,478
+167,708
+4% +$1.14M ﹤0.01% 2291
2017
Q1
$39M Buy
4,132,770
+1,304,487
+46% +$12.3M ﹤0.01% 2124
2016
Q4
$24.4M Buy
2,828,283
+48,806
+2% +$422K ﹤0.01% 2335
2016
Q3
$17.6M Buy
2,779,477
+42,086
+2% +$266K ﹤0.01% 2421
2016
Q2
$11.6M Buy
2,737,391
+241,227
+10% +$1.02M ﹤0.01% 2588
2016
Q1
$10.9M Buy
2,496,164
+122,039
+5% +$532K ﹤0.01% 2574
2015
Q4
$14.6M Buy
2,374,125
+34,224
+1% +$210K ﹤0.01% 2442
2015
Q3
$13.4M Buy
2,339,901
+72,979
+3% +$417K ﹤0.01% 2454
2015
Q2
$16.9M Buy
2,266,922
+46,154
+2% +$344K ﹤0.01% 2435
2015
Q1
$13.3M Buy
2,220,768
+126,001
+6% +$753K ﹤0.01% 2505
2014
Q4
$15.8M Buy
2,094,767
+32,179
+2% +$243K ﹤0.01% 2346
2014
Q3
$10.7M Buy
2,062,588
+141,126
+7% +$732K ﹤0.01% 2459
2014
Q2
$8.28M Buy
1,921,462
+65,664
+4% +$283K ﹤0.01% 2591
2014
Q1
$7.59M Buy
1,855,798
+388,831
+27% +$1.59M ﹤0.01% 2618
2013
Q4
$7.82M Sell
1,466,967
-38,531
-3% -$205K ﹤0.01% 2564
2013
Q3
$7.57M Buy
1,505,498
+248,814
+20% +$1.25M ﹤0.01% 2526
2013
Q2
$5.61M Buy
+1,256,684
New +$5.61M ﹤0.01% 2601